Menopausal hormone therapy in healthy women: a new look at an old topic?

Therapeutic personalisation II: pharmacogenetics

Therapeutic personalisation I: Practical aspects of pharmacokinetic monitoring

Beyond statins: evidence for other lipid-lowering drugs in patients with atherosclerotic cardiovascular disease

Surrogate outcomes and fast-track drug approval

Glucagon-like peptide 1 receptor agonists (GLP1a) and the problem of obesity

Use of fluid therapy in clinical practice

Safe drug use in patients with cirrhosis

Long-acting injectable antipsychotics in schizophrenia